Provided by Tiger Trade Technology Pte. Ltd.

EVEREST MED

39.760
+0.9002.32%
Volume:5.04M
Turnover:199.28M
Market Cap:14.08B
PE:-12.50
High:41.000
Open:38.860
Low:37.600
Close:38.860
52wk High:77.550
52wk Low:35.540
Shares:354.00M
HK Float Shares:354.00M
Volume Ratio:1.74
T/O Rate:1.42%
Dividend:- -
Dividend Rate:- -
EPS(LYR):-3.180
ROE:-23.04%
ROA:-9.09%
PB:3.18
PE(LYR):-12.50
PS:14.67

Loading ...

Everest MED Shares Surge Afternoon on New Drug Approval

Stock News
·
Feb 06

Everest Medicines (1952) Secures NMPA Approval for VELSIPITY® in China to Treat Moderately-to-Severely Active Ulcerative Colitis

Bulletin Express
·
Feb 06

EVEREST MED Receives Chinese Approval for VELSIPITY® to Treat Moderate to Severe Ulcerative Colitis

Stock News
·
Feb 06

Everest Medicines - Nmpa China Approves Drug Application for Velsipity for Ulcerative Colitis

THOMSON REUTERS
·
Feb 06

China Approves Everest Medicines' VELSIPITY for Moderately-to-Severely Active Ulcerative Colitis

Reuters
·
Feb 06

Everest Medicines (01952) Publishes January 2026 Monthly Return on Equity Movements

Bulletin Express
·
Feb 05

Everest Medicines Acquires License to Commercialize Kidney Drug MT1013

MT Newswires Live
·
Feb 05

BRIEF-Everest Medicines Inks Agreement With Micot To Commercialize MT1013

Reuters
·
Feb 05

EVEREST MED (01952) Strengthens Renal Portfolio with Global First-in-Class Dual-Target Peptide Drug MT1013

Stock News
·
Feb 05

EVEREST MED Subsidiary Inks Deal with Micot for Commercialization of MT1013 Across Greater China and Asian Markets

Stock News
·
Feb 05

Everest Medicines Ltd - Unit's Payment Obligations Include an Upfront Payment of RMB200 Mln, Others

THOMSON REUTERS
·
Feb 05

Everest Medicines schließt Lizenzvereinbarung mit Micot zur Kommerzialisierung von MT1013 in China und Asien

Reuters
·
Feb 05

Everest Medicines Ltd - Agreement With Micot to Commercialize Mt1013 in Greater China and Other Asian Markets

THOMSON REUTERS
·
Feb 05

Everest Medicines (1952) Announces Extraordinary General Meeting on 24 February 2026

Bulletin Express
·
Feb 03

Everest Medicines (1952) Announces Continuing Connected Transactions, Proposed Connected-Person Award, and 2026 Share Scheme

Bulletin Express
·
Feb 03

Everest Medicines (Stock Code: 1952) Announces Virtual EGM Arrangement for 24 February 2026

Bulletin Express
·
Feb 03

Everest Medicines (1952) Announces Virtual EGM Agenda and Share Schemes

Bulletin Express
·
Feb 03

Everest Medicines gibt Termin für außerordentliche Hauptversammlung bekannt

Reuters
·
Feb 03

Everest Medicines Limited (1952) Announces Book Closure Period for Extraordinary General Meeting

Bulletin Express
·
Feb 02

Everest Medicines Signs Lease Agreement for New Premises

Reuters
·
Jan 26